Last reviewed · How we verify
Kaposi's sarcoma
Approved treatments
- Daunorubicin Hydrochloride · Meiji Seika Pharma Co., Ltd
- Taxol · Pfizer
Taxol works by binding to tubulin and preventing the formation of microtubules, which are essential for cell division. - Daunorubicine · Gruppo Italiano Malattie EMatologiche dell'Adulto
- adriacin · Chipscreen Biosciences, Ltd.
- Hydroxydaunorubicin · University of Colorado, Denver
- Vinblastin · The Lymphoma Academic Research Organisation
- Taxol · Pfizer
- Liposomal Doxorubicin · Pfizer
- Taxol · Pfizer
- Doxorubicin Hydrochloride · Pfizer
Doxorubicin works by intercalating DNA strands and inhibiting topoisomerase II, an enzyme essential for DNA replication and cell division. - Hydroxydaunomycin · Weill Medical College of Cornell University
- Abraxane · The First Affiliated Hospital with Nanjing Medical University
- Adriamycin · Johann Wolfgang Goethe University Hospital
- Taxol · M.D. Anderson Cancer Center
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Kaposi's sarcoma patent landscape — cliff calendar, originator estates, attackable patents
- Kaposi's sarcoma treatment landscape brief
- Kaposi's sarcoma treatment updates RSS
Frequently asked questions about Kaposi's sarcoma
What drugs treat Kaposi's sarcoma?
Tracked treatments include Daunorubicin Hydrochloride, Taxol, Daunorubicine, adriacin, Hydroxydaunorubicin, Vinblastin, Liposomal Doxorubicin, Doxorubicin Hydrochloride.
What is the treatment for Kaposi's sarcoma?
Standard treatment for Kaposi's sarcoma includes Daunorubicin Hydrochloride, Taxol, Daunorubicine, adriacin, Hydroxydaunorubicin. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Kaposi's sarcoma patent cliff · Kaposi's sarcoma CI report
- Treatment: Daunorubicin Hydrochloride · Meiji Seika Pharma Co., Ltd
- Treatment: Taxol · Pfizer
- Treatment: Daunorubicine · Gruppo Italiano Malattie EMatologiche dell'Adulto
- Treatment: adriacin · Chipscreen Biosciences, Ltd.
- Treatment: Hydroxydaunorubicin · University of Colorado, Denver
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing